Jagsonpal Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 4/6
Jagsonpal Pharmaceuticals is a dividend paying company with a current yield of 0.84% that is well covered by earnings.
Key information
0.8%
Dividend yield
-0.4%
Buyback Yield
| Total Shareholder Yield | 0.4% |
| Future Dividend Yield | n/a |
| Dividend Growth | 8.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹5.000 |
| Payout ratio | 59% |
Recent dividend and buyback updates
Recent updates
Some Confidence Is Lacking In Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) P/E
Oct 14
There May Be Some Bright Spots In Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Earnings
May 27There's Reason For Concern Over Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Massive 27% Price Jump
Apr 30A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
Apr 05Investor Optimism Abounds Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) But Growth Is Lacking
Feb 06Estimating The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
Jul 29A Look At The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
May 13Does Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Deserve A Spot On Your Watchlist?
Jul 05A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
Jun 13Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) 0.6% Dividend Yield Looks Pretty Interesting
Apr 19Should You Be Adding Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) To Your Watchlist Today?
Mar 21Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Stock Is Going Strong: Have Financials A Role To Play?
Feb 08The Attractive Combination That Could Earn Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) A Place In Your Dividend Portfolio
Jan 08Here's Why I Think Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Is An Interesting Stock
Dec 21Are Jagsonpal Pharmaceuticals's (NSE:JAGSNPHARM) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 30Stability and Growth of Payments
Fetching dividends data
Stable Dividend: JAGSNPHARM's dividend payments have been volatile in the past 10 years.
Growing Dividend: JAGSNPHARM's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Jagsonpal Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (JAGSNPHARM) | 0.8% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (JAGSNPHARM) (up to 3 years) | n/a |
Notable Dividend: JAGSNPHARM's dividend (0.84%) is higher than the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: JAGSNPHARM's dividend (0.84%) is low compared to the top 25% of dividend payers in the Indian market (1.14%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (58.9%), JAGSNPHARM's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (23.2%), JAGSNPHARM's dividend payments are well covered by cash flows.